Xlife Sciences Ltd. header image

Xlife Sciences Ltd.

XLS

Equity

ISIN CH0461929603 / Valor 46192960

SIX Swiss Exchange (2026-10-30)
CHF 8.80-0.23%

Xlife Sciences Ltd.
UMushroom community rating:

star star star star star
3.50 2 votes No rating yet
NegativeNeutralPositive

About company

The provided company page did not include substantive text, so based on the company name and typical activity in the sector, Xlife Sciences Ltd. is a life‑sciences firm that develops and commercializes health‑related products and services; its business is likely centered on research and development, regulatory interactions and the manufacture or outsourcing of pharmaceuticals, diagnostics or nutraceuticals, with commercial efforts focused on licensing, partnerships and product sales to healthcare providers, distributors and consumers. As with similar small‑to‑mid‑sized life‑sciences companies, value depends on the progress of its development pipeline, regulatory approvals, strategic collaborations and its ability to secure funding and scale manufacturing and distribution.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-56.0%1Y
-75.8%3Y
-80.6%5Y

Performance

62.6%1Y
64.2%3Y
60.8%5Y

Volatility

Market cap

62 M

Market cap (USD)

Daily traded volume (Shares)

3,653

Daily traded volume (Shares)

1 day high/low

25.9 / 24.8

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

3.50

2 votes
Performance:
starstarstarstarstar
3.00
Innovation:
starstarstarstarstar
3.00
Society:
starstarstarstarstar
3.00
Nature:
starstarstarstarstar
3.00
Timo R
Switzerland, 16 Apr 2025
star star star star star
.
Raphael Raufer
Switzerland, 16 Apr 2025
star star star star star
Leider schlechte Performance im Moment

EQUITIES OF THE SAME SECTOR

Omnicell Inc
Omnicell Inc Omnicell Inc Valor: 1275961
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.62%USD 36.65
Xenon Pharmaceuticals Inc
Xenon Pharmaceuticals Inc Xenon Pharmaceuticals Inc Valor: 25419823
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.35%USD 37.41
Trupanion Inc
Trupanion Inc Trupanion Inc Valor: 24738737
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.20%USD 30.13
Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB Valor: 2676862
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.45%SEK 490.20
Biogen Inc
Biogen Inc Biogen Inc Valor: 1720684
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.59%USD 253.62
Dr. Lal PathLabs Limited
Dr. Lal PathLabs Limited Dr. Lal PathLabs Limited Valor: 30691066
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.37%INR 1,906.30
PolyPeptide Group Ltd
PolyPeptide Group Ltd PolyPeptide Group Ltd Valor: 111076085
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.23%CHF 42.00
Summit Therapeutics Inc
Summit Therapeutics Inc Summit Therapeutics Inc Valor: 56903013
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.05%USD 16.03
BioArctic AB
BioArctic AB BioArctic AB Valor: 38514501
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.69%SEK 317.20
Essity AB
Essity AB Essity AB Valor: 36846754
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.82%SEK 279.50